发明授权
US07947720B2 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
有权
3,4-二取代的环丁烯-1,2-二酮作为CXC-趋化因子受体配体
- 专利标题： 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
- 专利标题（中）： 3,4-二取代的环丁烯-1,2-二酮作为CXC-趋化因子受体配体
-
申请号： US12352781申请日： 2009-01-13
-
公开(公告)号： US07947720B2公开(公告)日： 2011-05-24
- 发明人: Arthur G. Taveras , Cynthia J. Aki , Richard W. Bond , Jianping Chao , Michael Dwyer , Johan A. Ferreira , Jianhua Chao , Younong Yu , John J. Baldwin , Bernd Kaiser , Ge Li , J. Robert Merritt , Purakkattle J. Biju , Kingsley H. Nelson, Jr. , Laura L. Rokosz
- 申请人： Arthur G. Taveras , Cynthia J. Aki , Richard W. Bond , Jianping Chao , Michael Dwyer , Johan A. Ferreira , Jianhua Chao , Younong Yu , John J. Baldwin , Bernd Kaiser , Ge Li , J. Robert Merritt , Purakkattle J. Biju , Kingsley H. Nelson, Jr. , Laura L. Rokosz
- 申请人地址： US NJ Kenilworth US NJ Cranbury
- 专利权人： Schering Corporation,Pharmacopeia Drug Discovery
- 当前专利权人： Schering Corporation,Pharmacopeia Drug Discovery
- 当前专利权人地址： US NJ Kenilworth US NJ Cranbury
- 代理商 Eric A. Meade; Henry C. Jeanette
- 主分类号： C07D261/04
- IPC分类号： C07D261/04 ; C07D327/04 ; A01N43/80 ; A01N43/06
摘要：
There are disclosed compounds of the formula or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.
公开/授权文献
信息查询
